基于数据挖掘分析中医药治疗儿童幽门螺杆菌感染相关再发性腹痛的用药特点

doi:10.20274/j.cnki.issn.1674-3865.2026.05.011

Abstract

Abstract:

Objective To analyze the prescription patterns of traditional Chinese medicine in the treatment of Helicobacter pylori infection-related recurrent abdominal pain in children based on data mining. Methods Clinical traditional Chinese medicine prescription data were collected from children with Helicobacter pylori infection-related recurrent abdominal pain who attended the pediatric outpatient department of the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine from January 2024 to September 2025, and a prescription database was subsequently established. The properties, flavors, meridian tropisms, and use frequencies of the drugs were statistically analyzed using Microsoft Excel. Association rule analysis and cluster analysis were performed with R language to identify core drug combinations. Results A total of 86 children were included, yielding 104 effective prescriptions involving 98 Chinese herbal medicines. The medicinal properties were predominantly warm, cold, and neutral; the flavors were mainly sweet, bitter, and pungent; the meridian tropisms were concentrated in the stomach, spleen, lung, and liver meridians. The top 10 high-frequency drugs were Chaihu(Bupleuri Radix, 90 times), Yanhusuo(Corydalis Rhizoma, 72 times), Shenqu(Massa Medicata Fermentata, 71 times), Chenpi(Citri Reticulatae Pericarpium, 61 times), Baishao(Paeoniae Radix Alba, 52 times), Laifuzi(Raphani Semen, 52 times), Shanyao(Dioscoreae Rhizoma, 52 times), Sharen(Amomi Fructus, 51 times), Huangqin(Scutellariae Radix, 50 times), and Baizhu(Atractylodis Macrocephalae Rhizoma, 50 times). Association rule analysis revealed that the top 5 combinations were as follows: {Yanhusuo, Zheshi(Haematitum)}?{Xuanfuhua(Inulae Flos)}, {Yanhusuo, Shenqu, Baizhu} ? {Fuling(Poria)}, {Chaihu, Yanhusuo, Shenqu, Baizhu}?{Fuling}, {Chaihu, Shenqu, Zheshi} ? {Xuanfuhua}, and {Shenqu, Chenpi, Baizhu}?{Fuling}. Cluster analysis categorized the high-frequency drugs into 5 classes: C1 included Sharen, Laifuzi, Jineijin(Galli Gigerii Endothelium Corneum), Shanzha(Crataegi Fructus), and Houpo(Magnoliae Officinalis Cortex); C2 included Chenpi, Chaihu, Yanhusuo, and Shenqu; C3 included Muxiang(Aucklandiae Radix), Baizhu, Fuling, Baishao, Ezhu(Curcumae Rhizoma), and Shanyao; C4 consisted of Zheshi, Xuanfuhua, and Zhiqiao(Aurantii Fructus); C5(herbal pair) comprised Huangqin and Huanglian(Coptidis Rhizoma). Based on the high-frequency drugs, association rules, and clustering results, "Chaihu-Yanhusuo-Shenqu-Baizhu-Fuling" was identified as the core prescription. Conclusion The treatment for Helicobacter pylori infection-related recurrent abdominal pain in children follows the principles of supporting healthy Qi and eliminating pathogenic factors, and invigorating the spleen and protecting the stomach. "Chaihu–Yanhusuo–Shenqu–Baizhu–Fuling" can be recommended as the core prescription.

Key words: Recurrent abdominal pain, Helicobacter pylori, Data mining, Child

CLC Number:

R256.33

Jiahui LIU, Hanjing WANG, Yuting ZHANG, Xue LAN, Weiwei LIU. Medication characteristics of traditional Chinese medicine in the treatment of Helicobacter pylori infection-related recurrent abdominal pain in children: a data mining analysis[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 430-435.

Figures/Tables 8

Table 1

Fig. 1

Fig. 2

Fig. 3

Table 2

Fig. 4

Fig. 5

Fig. 6

References 30

[1]	Mattson JT, Thorne JC, Kover ST. Relationship between task-based and parent report-based measures of attention and executive function in children with fetal alcohol spectrum disorders(FASD)[J]. J Pediatr Neuropsychol, 2020,6(3):176-188.
[2]	师梦,谢庆芝,张雨萌,等.幽门螺杆菌分型检测在儿童再发性腹痛中的应用价值[J].国际医药卫生导报,2019,25(9):1432-1435.
[3]	高凯悦,李海文.幽门螺旋杆菌与胃癌间关系的研究进展[J].胃肠病学和肝病学杂志,2025,34(4):582-585.
[4]	中华医学会消化病学分会幽门螺杆菌学组.第六次全国幽门螺杆菌感染处理共识报告（非根除治疗部分）[J].胃肠病学,2022,27(5):289-304.
[5]	Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of helicobacter pylori infection: systematic review and Meta-analysis[J]. Gastroenterology， 2017，153(2):420-429.
[6]	冯正平,梁杏花,刘佛球.2191例消化性溃疡的胃镜和流行病学分析[J].重庆医学,2020,49(7):1114-1117.
[7]	Yuan C, Adeloye D, Luk TT, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis[J]. Lancet Child Adolesc Health， 2022，6(3):185-194.
[8]	黎文鸿,李紫薇,汪娜,等.中国儿童幽门螺杆菌感染现状及其影响因素的Meta分析[J].中国全科医学,2022,25(28):3569-3578.
[9]	张博,高乔乔,程艳波,等.幽门螺杆菌感染与儿童营养不良的相关性[J].卫生研究,2021,50(5):864-867.
[10]	钟成侃.除幽方治疗耐药性幽门螺旋杆菌感染的临床观察及机制初探[D].杭州：浙江中医药大学,2022.
[11]	李煜杰. 儿童幽门螺旋杆菌感染治疗进展[J]. 中国城乡企业卫生,2022,37(8):60-62.
[12]	刘子熙,侯林.中药治疗幽门螺旋杆菌感染的研究进展[J].药学前沿,2024,28(9):144-154.
[13]	中华医学会儿科学分会消化学组,国家儿童医学中心消化专科联盟,中华儿科杂志编辑委员会,等.中国儿童幽门螺杆菌感染诊治专家共识(2022)[J].中华儿科杂志,2023,61(7):580-587.
[14]	江载芳,申昆玲,沈颖．诸福棠实用儿科学[M]．8版．北京:人民卫生出版社,2015.
[15]	国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2025.
[16]	钟赣生,杨柏灿.中药学[M].5版.北京:中国中医药出版社,2021.
[17]	王庆,陈雅琴,殷丹飞,等.基于数据挖掘的王晓鸣教授治疗小儿积滞组方规律探索[J].中国中西医结合儿科学, 2025, 17(6):466-471.
[18]	孙远航,李冬梅.基于数据挖掘分析现代名中医治疗抽动障碍的用药规律[J].中国中西医结合儿科学,2025,17(4):281-286.
[19]	张艺展,徐荣佳,姜晨.基于数据挖掘和网络药理学探究中医药治疗腹膜透析相关性腹膜炎的用药规律及作用机制[J].中草药,2025,56(21):7883-7895.
[20]	由立忠. 幽门螺旋杆菌感染的中医认识[J]. 世界最新医学信息文摘（连续型电子期刊）,2016,16(19):156-157.
[21]	马文倩,黄学宽,刘西洋.基于肝脾同调法治疗胃溃疡肝胃不和型临证体会[J].实用中医药杂志,2026,42(1):182-184.
[22]	中国中西医结合学会消化系统疾病专业委员会,张声生,吴震宇,等.幽门螺杆菌感染中西医结合诊疗专家共识(2025年)[J].中国中西医结合消化杂志, 2025，33(11):1016-1028.
[23]	Li XH, Xu JY, Wang X, et al. BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism[J]. World J Gastroenterol， 2023，29(18):2818-2835.
[24]	李瑞奇,苗明三.药性温的现代研究及相互关系[J].中医学报,2012,27(11):1456-1459.
[25]	Zhang X, Wang G, Kuang W, et al. Discovery and evolution of berberine analogues as anti-Helicobacter pylori agents with multi-target mechanisms[J]. Bioorg Chem， 2024，151:107628.
[26]	Jeong SY, Kang DM, Kim HJ, et al. Anti-Helicobacter pylori and Anti-Inflammatory Sesquiterpenoids from the Rhizoma of Atractylodes macrocephala[J]. Molecules， 2025，30(15):3142.
[27]	赵琰,郑敏,赵沛东,等.从脾胃论治幽门螺杆菌感染研究进展[J].中国中西医结合消化杂志, 2024, 32(10):929-933.
[28]	肖开,苗明三.药性寒的特点及现代研究[J].中医学报,2013,28(7):1006-1008.
[29]	Tang Q, Ma Z, Tang X, et al. Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo[J]. J Ethnopharmacol， 2023，314:116618.
[30]	Dmitrieva A, Kozlova O, Atuchin V, et al. Study of the effect of baicalin from Scutellaria baicalensis on the gastrointestinal tract normoflora and Helicobacter pylori [J]. Int J Mol Sci， 2023，24(15):11906.

序号	中药关联规则	提升度	支持度（%）	置信度（%）	序号	中药关联规则	提升度	支持度（%）	置信度（%）
1	{延胡索、赭石}=>{旋覆花}	2.21	20.19	95.45	11	{赭石}=>{旋覆花}	2.05	29.81	88.57
2	{延胡索、神曲、白术}=>{茯苓}	2.03	20.19	95.45	12	{柴胡、神曲、白术}=>{茯苓}	1.88	22.12	88.46
3	{柴胡、延胡索、神曲、白术}=>{茯苓}	2.03	20.19	95.45	13	{延胡索、黄连}=>{黄芩}	1.84	22.12	88.46
4	{柴胡、神曲、赭石}=>{旋覆花}	2.13	23.08	92.31	14	{延胡索、白术}=>{茯苓}	1.87	27.88	87.88
5	{神曲、陈皮、白术}=>{茯苓}	1.95	21.15	91.67	15	{黄连}=>{黄芩}	1.77	27.88	85.29
6	{柴胡、赭石}=>{旋覆花}	2.09	26.92	90.32	16	{柴胡、神曲、茯苓}=>{白术}	1.77	22.12	85.19
7	{柴胡、延胡索、白术}=>{茯苓}	1.92	26.92	90.32	17	{黄芩、枳壳}=>{旋覆花}	1.96	21.15	84.62
8	{神曲、赭石}=>{旋覆花}	2.08	25.96	90.00	18	{柴胡、黄芩、枳壳}=>{旋覆花}	1.94	20.19	84.00
9	{神曲、白术}=>{茯苓}	1.91	25.96	90.00	19	{柴胡、陈皮、白术}=>{茯苓}	1.78	20.19	84.00
10	{柴胡、黄连}=>{黄芩}	1.85	23.08	88.89	20	{陈皮、白术}=>{茯苓}	1.78	25.00	83.87

Medication characteristics of traditional Chinese medicine in the treatment of Helicobacter pylori infection-related recurrent abdominal pain in children: a data mining analysis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 8

References 30

Related Articles 15

Recommended Articles

Metrics

Comments

序号	中药	频次	序号	中药	频次
1	柴胡	90	11	茯苓	49
2	延胡索	72	12	木香	45
3	神曲	71	13	旋覆花	45
4	陈皮	61	14	枳壳	45
5	白芍	52	15	鸡内金	42
6	莱菔子	52	16	山楂	42
7	山药	52	17	莪术	39
8	砂仁	51	18	赭石	35
9	白术	50	19	厚朴	34
10	黄芩	50	20	黄连	34

[1]	Siyuan HU, Qinglong GU, Xuefeng WANG, Fengying QIAO, Rong MA, Daxin LIU, Qiuhan CAI, Yan CHEN. Expert consensus on the diagnosis, treatment and efficacy evaluation of pediatric acute rhinosinusitis in integrated traditional Chinese and Western medicine [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 369-375.
[2]	Yilin CHEN, Yating ZHANG, Hui LI. Treating pediatric functional constipation of Qi-Yin deficiency syndrome based on the theory of "tonifying to relieve obstruction" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 381-385.
[3]	Hongjie HAO, Xiaozheng DUAN, Aoning LIU. Experience in treating pediatric constipation of food accumulation and lung-heat syndrome based on the theory of "Sanjiao Qi transformation" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 386-390.
[4]	Hui LIU, Xiaojuan XU, Mingming GENG. Research progress on early diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 391-398.
[5]	Xinrui ZHANG, Mingxin E, Xuefeng WANG, Xiuying ZHANG, Jingwen MU. First-round Delphi expert consultation on traditional Chinese medicine syndromes of functional dyspepsia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 399-407.
[6]	Bo LI, Jiaoyan LIAO, Zijing LIAO, Tingting ZHU, Feng ZHANG. Analysis of rehabilitation efficacy of sling exercise training combined with press needle therapy in spastic diplegic cerebral palsy [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 413-418.
[7]	Yaowei HAN, Huizhe WANG, Huanmin LI, Liting MA, Dan SUN, Hongxiang CHEN, Shuo YANG, Kunya FU, Mingze LIU, Xinmin LI. Clinical observation of the "Qingxuan Tongluo" method in the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 419-424.
[8]	Huafang LIANG, Na GAN, Lining WANG, Jianshu WEI, Yi LIANG. Analysis of medication rules and clinical experience of Professor Wang Lining in treating pediatric recurrent respiratory tract infections during the acute infection phase [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 425-429.
[9]	Siyuan XU, Dan DONG, Xuefeng WANG. Research progress in the treatment of short stature in children based on the five internal organs [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(4): 283-288.
[10]	Hongyun ZHAO, Fang HE, Chengcheng HUANG, Yang YANG, Shaohua LIU, Weichao JING. An exploration into chronic cough-induced short stature in children based on the theory of "Prolonged damage to the five Zang-organs eventually affects the kidney" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(4): 289-295.
[11]	Yang YANG, Wei HUANG. Exploring the therapeutic effects of Xiaoyao powder on short stature in children with liver depression and spleen deficiency based on the "Opening-Closing Pivot" theory [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(4): 300-304.
[12]	Yuanqi LUO, Leiming XI. Study on the clinical mechanism of traditional Chinese medicine in the treatment of adenoid hypertrophy in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(4): 305-308.
[13]	Yumeng SU, Oumei HAO, Xuefeng WANG, Kexin ZHANG. Differential treatment for pediatric chronic cough based on the theory of "Xuanfu-Qiye-Sanjiao" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(4): 309-313.
[14]	Yan LIN, Zhiyan JIANG. Exploring the clinical application of the concept of "regulating the spleen to treat nasal disorders" in the treatment of severe AH complicated with ADHD from the comorbidity perspective [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(4): 314-317.
[15]	Lihua GUO, si AI, Xueqi FAN. An analysis of childhood obesity based on the theory of "immature Yin-Yang" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(4): 318-322.